Biologic Therapy Does Not Increase Postoperative Complication in Crohn's Disease

被引：0
|
作者：
Alhamly, Hadeel Z. M.
Qadhi, Iman N.
Al-rubaiah, Rawan
Alabbad, Jasim Y.
Raheem, Fawaz Abdul
机构：
[1] Kuwait Inst Med Specializat, Kuwait, Kuwait
[2] Minist Hlth, Jabriya, Kuwait
[3] Kuwait Inst Med Specializat, Safat, Kuwait
[4] Minist Hlth, Al Asimah, Kuwait
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2023年 / 237卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [1] Infliximab does not increase postoperative complication rates in patients with Crohn's disease
    Marchal, L
    D'Haens, G
    Van Assche, G
    Hiele, M
    D'Hoore, A
    Penninckx, F
    Rutgeerts, P
    GASTROENTEROLOGY, 2003, 124 (04) : A207 - A207
  • [2] Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients
    Lightner, Amy L.
    McKenna, Nicholas P.
    Alsughayer, Ahmad
    Loftus, Edward V., Jr.
    Raffals, Laura E.
    Faubion, William A.
    Moir, Christopher
    JOURNAL OF PEDIATRIC SURGERY, 2019, 54 (10) : 2162 - 2165
  • [3] Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients
    Ahmad, Alsughayer
    Nicholas, McKenna
    Loftus, Jr Edward
    Laura, Raffals
    William, Faubion
    Amy, Lightner
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S26 - S26
  • [4] IMMUNOSUPPRESSIVE THERAPY DOES NOT INCREASE POSTOPERATIVE MORBIDITY IN PATIENTS WITH CROHN'S DISEASE.
    Bafford, A.
    Powers, S.
    Ha, C.
    Gorfine, S.
    Chessin, D.
    Bauer, J.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 605 - 605
  • [5] Inummosuppression with steroids or azathioprine does not increase the postoperative complication rate in abdominal surgery for Crohn's disease
    Kuper, M
    Dinescu, A
    Mueller, MH
    Meile, T
    Kasparek, M
    Glatzle, J
    Jehle, EC
    Kreis, ME
    Zittel, TT
    GASTROENTEROLOGY, 2004, 126 (04) : A805 - A805
  • [6] Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not increase Risk of Adverse Outcomes
    Ungaro, Ryan C.
    Limketkai, Berkeley N.
    Jensen, Camilla Bjorn
    Yzet, Clara
    Allin, Kristine H.
    Agrawal, Manasi
    Ullman, Thomas
    Burisch, Johan
    Jess, Tine
    Colombel, Jean-Frederic
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (05) : 1152 - +
  • [7] Response to Biologic Therapy in Crohn's Disease Does Not Differ By Race
    Patil, Seema
    Ghazi, Leyla
    Rustgi, Ankur
    Cross, Raymond
    Flasar, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S471 - S471
  • [8] Optimization of biologic therapy in Crohn's disease
    Razvi, Mohammed
    Lazarev, Mark
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (03) : 263 - 272
  • [9] Overview of biologic therapy for Crohn's disease
    Dryden, Gerald W., Jr.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (08) : 967 - 974
  • [10] Postoperative Therapy for Crohn's Disease
    Blum, Eric
    Katz, Jeffry A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (03) : 463 - 472
12345